So are we! We’re pleased to share that Jonathan Miller, CSI’s Head of Operations, North America, will be attending Jefferies New York 2025 this June. If you’re a pharmaceutical or biotech company with comparator drugs in your pipeline, from early planning to on-demand global delivery, Jonathan would be happy to connect. Clinical Services International specializes in supporting complex, high-value clinical trials across all therapeutic areas. 📅 Let’s set up a meeting to explo

Client Request A leading global biopharmaceutical company approached CSI with an urgent need for the Fluarix QIV Southern Hemisphere Vaccine 2025. The requirements included: Quantity: 10,000 doses Delivery Date: As soon as possible (urgent) Delivery Location: Singapore Batch Preference: Multiple lots acceptable if necessary The Challenge The client was let down by a supplier in Brazil and needed to secure alternative stock at the last minute. Complicating matters, the Fluarix

A Global Pharmaceutical Sponsor’s Challenge A global pharmaceutical sponsor conducting a Phase III clinical trial needed Semaglutide, a GLP-1 receptor agonist, as a comparator drug. The study spanned multiple regions, including North America, Europe, and Asia-Pacific. This required a consistent and compliant supply of the drug across various regulatory landscapes. The sponsor needed a reliable partner to source Semaglutide efficiently while ensuring batch consistency, Certifi

CSI attended the Global Clinical Supplies Group (GCSG) US Conference in San Antonio, Texas, April 27th-30th. The event brought together clinical supply professionals from around the world to discuss industry trends, challenges and strategies for your clinical trial pipeline. CSI’s Managing Director, Vanessa Dekou, hosted a successful and sell-out workshop at GCSG US, to share over 25 years’ worth of expert insights on the complexities of comparator sourcing strategies. If yo

Exciting news! CSI will be exhibiting at GCSG Asia Pacific 2024 this week, on March 12-13 in Seoul! Visit us at Table 7 to learn how our expert clinical supply solutions can streamline your global trial supplies. Let’s connect and explore how CSI’s direct manufacturer relationships, scientific expertise and sustainable sourcing can support your study needs. See you there! 👋

Which Trends Will Shape Clinical Trial Supplies in 2025? The clinical trial supply industry is rapidly evolving. This change is driven by...

The clinical trial supply chain is a critical component of drug development, involving the manufacturing, sourcing, packaging, labelling,...

Learn about CSI’s expert risk management strategies One of the biggest challenges faced by clinical trial supply management companies are...

Globalised clinical trials face a number of challenges when it comes to sourcing, supplying packaging and labelling and distributing...

Oncology products monopolise the list of best-selling drugs. With a huge range of indications that is only growing, therapies become more specific to tumour or cell pathologies and increasing patient numbers. Several oncology products now have ‘blockbuster’ status where sales exceed $1 billion annually. This is relevant for clinical trials as more regulators require evidence of efficacy in comparison to the standard of care, which is likely to be one of the blockbuster produc